The Fibrosure test is a blood test which measures several different naturally occurring substances in the blood which give an indirect indication of chronic liver inflammation and through a mathematical calculation this is converted to a score for fibrosis.
Non-invasive tests are being developed to replace liver biopsy, and thus avoid the risk of biopsy-related adverse events. Non-invasive tests also have the potential to avoid limitations of liver biopsy, including the risk of sampling errors and inter-and intra-pathologist variability. The FibroSpect II (Prometheus Laboratories, San Diego, CA) is a non-invasive diagnostic panel to assist in the detection of liver fibrosis. Furthermore, an UpToDate review on “Tests used for the noninvasive assessment of hepatic fibrosis” (Curry and Afdhal, 2013) states that “While tremendous progress has been made in improving the accuracy of serum markers of hepatic fibrosis, they cannot yet supplant direct analysis of the liver. I just got my first FibroSure test results back. My new Dr. ordered this kind of test to gage what condition my liver is at. Apparently this is the new kind of testing they use instead of a liver biopsy.I have been reading that this type of testing is very unreliable. The test that I just got back shows me at a stage 3 going into a stage 4. Can anyone give me information on these types of test and your personal experience with them. Its hard for me to believe that my liver could of deteriorated that much in only 4 years. Unfortunately I also have short bowel and am TPN dependent,which is also hard on the liver The stage of fibrosis is the most important single predictor of significant morbidity and mortality in individuals with hepatitis C and other chronic liver diseases. HCV FibroSURE should not be ordered if patients have any of the following conditions: Gilbert Disease, acute hemolysis associated with ribavirin therapy, acute hepatitis, extra-hepatic cholestasis, transplant patients, and/or renal insufficiency patients. New test for Cirrhosis. A new test to determine if fibrosis (cirrhosis) is present in the liver is now available and is a breakthrough for patients with liver disease. This new test is called a Fibrosure or Fibrotest. In the past, the standard test to determine the physical state of the liver tissue was a liver biopsy. Cirrhosis is caused by scar tissue building up in the liver. The Fibrosure blood test measures the amount of the following substances in your blood: Alpha 2 macroglobulins (normal range = 110 to 276 mg/dL). Haptoglobulin (normal range = 34 to 200 mg/dL). FibroMeter is a family of blood tests assessing liver fibrosis and cirrhosis stage. Based on clinical parameters data along with biochemical markers, these tests constitute a complete range of tests covering the main liver diseases.  Investigators have sought a noninvasive alternative to liver biopsy for both as an initial assessment and then as a monitoring tool to assess response to therapy. A variety of laboratory tests have been proposed as an alternative to liver biopsy. HCV FibroSURE should not be ordered if patients have any of the following conditions: Gilbert Disease, acute hemolysis associated with ribavirin therapy, acute hepatitis, extra-hepatic cholestasis, transplant patients, and/or renal insufficiency patients. Please discuss further on the talk page. (September 2009). FibroTest, known as FibroSure in the US, is a patented biomarker test that uses the results of six blood serum tests to generate a score that is correlated with the degree of liver damage in people with a variety of liver diseases. FibroTest tests and derivatives are patented since 2001 by APHP (Assistance publique-Hopitaux hôpitaux De), paris The parisian public hospital. System in THE, FibroTest fibrotest is marketed FibroSure (fibrosure LabCorp labcorp). trademark The Fibrosure test is a blood test which measures several different naturally occurring substances in the blood which give an indirect indication of chronic liver inflammation and through a mathematical calculation this is converted to a score for fibrosis. Fibrosis is the same as scarring. Cirrhosis is caused by scar tissue building up in the liver. The Fibrosure blood test measures the amount of the following substances in your blood: Alpha 2 macroglobulins (normal range = 110 to 276 mg/dL). Haptoglobulin (normal range = 34 to 200 mg/dL). Objectives: Extent of liver fibrosis is one of the most important factors in determining prognosis and the need for active treatment in chronic hepatitis B (CHB). Noninvasive alternatives such as FibroTest/Fibrosure (FT) have been developed in order to overcome the shortcomings of liver biopsy (LB). 
http://www.aetna.com/cpb/medical/data/600_699/0690.html http://www.inspire.com/groups/american-liver-foundation/discussion/fibrosure-testing-1/ http://www.clinlabnavigator.com/fibrosure.html https://www.liverdoctor.com/new-test-for-cirrhosis-of-liver/ https://www.fibrometer.com/en/ http://www.clinlabnavigator.com/fibrosure.html https://en.wikipedia.org/wiki/FibroTest https://www.liverdoctor.com/new-test-for-cirrhosis-of-liver/ http://www.medscape.com/viewarticle/826834
what is a fibrosure blood test